Skip to main content
Top
Published in: Respiratory Research 1/2017

Open Access 01-12-2017 | Research

Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation

Authors: Enric Domingo, Juan C. Grignola, Rio Aguilar, Manuel López Messeguer, Antonio Roman

Published in: Respiratory Research | Issue 1/2017

Login to get access

Abstract

Background

Pulmonary hypertension (PH) associated with lung disease has the worst prognosis of all types of PH. Pulmonary arterial vasculopathy is an early event in the natural history of chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). The present study characterized the alterations in the structure and function of the pulmonary arterial (PA) wall of COPD and ILD candidates for lung transplantation (LTx).

Methods

A cohort of 73 patients, 63 pre-LTx (30 COPD, 33 ILD), and ten controls underwent simultaneous right heart catheterisation and intravascular ultrasound (IVUS). Total pulmonary resistance (TPR), capacitance (Cp), and the TPR-Cp relationship were assessed. PA stiffness and the relative area of wall thickness were estimated as pulse PA pressure/IVUS pulsatility and as [(external sectional area-intimal area)/external sectional area] × 100, respectively.

Results

Twenty-seven percent of patients had pulmonary arterial wedge pressure > 15 mmHg and were not analyzed. PA stiffness and the area of wall thickness were increased in comparison with controls, even in patients without PH (p < 0.05). ILD patients showed a significant higher PA stiffness, and lower Cp beyond mean PA pressure (mPAP) and lower area of wall thickness than COPD patients (p < 0.05). TPR-Cp relationship was shifted downward left for ILD patients.

Conclusions

Significant increase of PA stiffness and area of wall thickness were present even in patients without PH and can make the diagnosis of pulmonary vasculopathy at a preclinical stage in PH-lung disease candidates for LTx. ILD patients showed the worst PA stiffness and Cp with respect to COPD.
Literature
1.
go back to reference Andersen CU, Mellemkjaer S, Nielsen-Kudsk JE, Bendstrup E, Hilberg O, Simonsen U. Pulmonary hypertension in chronic obstructive and interstitial lung diseases. Int J Cardiol. 2013;168:1795–804.CrossRefPubMed Andersen CU, Mellemkjaer S, Nielsen-Kudsk JE, Bendstrup E, Hilberg O, Simonsen U. Pulmonary hypertension in chronic obstructive and interstitial lung diseases. Int J Cardiol. 2013;168:1795–804.CrossRefPubMed
2.
go back to reference Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2013;41:1292–301.CrossRefPubMed Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2013;41:1292–301.CrossRefPubMed
3.
go back to reference Shino MY, Lynch JP 3rd, Saggar R, Abtin F, Belperio JA, Saggar R. Pulmonary hypertension complicating interstitial lung disease and COPD. Semin Respir Crit Care Med. 2013;34:600–19.CrossRefPubMed Shino MY, Lynch JP 3rd, Saggar R, Abtin F, Belperio JA, Saggar R. Pulmonary hypertension complicating interstitial lung disease and COPD. Semin Respir Crit Care Med. 2013;34:600–19.CrossRefPubMed
4.
go back to reference Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877–82.CrossRefPubMed Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, et al. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877–82.CrossRefPubMed
5.
go back to reference Thabut G, Dauriat G, Stern JB, Logeart D, Levy A, Marrash-Chahla R, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–6.CrossRefPubMed Thabut G, Dauriat G, Stern JB, Logeart D, Levy A, Marrash-Chahla R, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–6.CrossRefPubMed
6.
go back to reference Hayes Jr D, Black SM, Tobias JD, Mansour HM, Whitson BA. Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation. COPD. 2016;13:50–6.CrossRefPubMed Hayes Jr D, Black SM, Tobias JD, Mansour HM, Whitson BA. Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation. COPD. 2016;13:50–6.CrossRefPubMed
7.
go back to reference Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746–52.CrossRefPubMed Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746–52.CrossRefPubMed
8.
go back to reference Nathan SD. Pulmonary hypertension in interstitial lung disease. Int J Clin Pract Suppl. 2008;62:21–28.CrossRef Nathan SD. Pulmonary hypertension in interstitial lung disease. Int J Clin Pract Suppl. 2008;62:21–28.CrossRef
9.
go back to reference Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, et al. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:616S–7S.CrossRefPubMed Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, et al. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:616S–7S.CrossRefPubMed
10.
go back to reference Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J. 2007;30:715–21.CrossRefPubMed Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J. 2007;30:715–21.CrossRefPubMed
11.
go back to reference Shlobin OA, Brown AW, Nathan SD. Pulmonary hypertension in diffuse parenchymal lung diseases. Chest. 2017;151:204–14.CrossRefPubMed Shlobin OA, Brown AW, Nathan SD. Pulmonary hypertension in diffuse parenchymal lung diseases. Chest. 2017;151:204–14.CrossRefPubMed
12.
go back to reference Carlsen J, Hasseriis Andersen K, Boesgaard S, Iversen M, Steinbruchel D, Bogelund AC. Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. J Heart Lung Transplant. 2013;32:347–54.CrossRefPubMed Carlsen J, Hasseriis Andersen K, Boesgaard S, Iversen M, Steinbruchel D, Bogelund AC. Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. J Heart Lung Transplant. 2013;32:347–54.CrossRefPubMed
13.
go back to reference Hayes Jr D, Higgins RS, Black SM, Wehr AM, Lehman AM, Kirkby S, et al. Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the united network of organ sharing registry. J Heart Lung Transplant. 2015;34:430–7.CrossRefPubMed Hayes Jr D, Higgins RS, Black SM, Wehr AM, Lehman AM, Kirkby S, et al. Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the united network of organ sharing registry. J Heart Lung Transplant. 2015;34:430–7.CrossRefPubMed
14.
go back to reference Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the pulmonary scientific council of the international society for heart and lung transplantation. J Heart Lung Transplant. 2006;25:745–55.CrossRefPubMed Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the pulmonary scientific council of the international society for heart and lung transplantation. J Heart Lung Transplant. 2006;25:745–55.CrossRefPubMed
15.
go back to reference Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterisation. Eur Respir J. 2013;42:1586–94.CrossRefPubMed Kovacs G, Avian A, Olschewski A, Olschewski H. Zero reference level for right heart catheterisation. Eur Respir J. 2013;42:1586–94.CrossRefPubMed
16.
go back to reference Dehmer GJ, Firth BG, Hillis LD. Oxygen consumption in adult patients during cardiac catheterization. Clin Cardiol. 1982;5:436–40.CrossRefPubMed Dehmer GJ, Firth BG, Hillis LD. Oxygen consumption in adult patients during cardiac catheterization. Clin Cardiol. 1982;5:436–40.CrossRefPubMed
17.
go back to reference Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 esc/ers guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS): Endorsed by: Association for european paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2016;37:67–119. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 esc/ers guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS): Endorsed by: Association for european paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
18.
go back to reference Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.CrossRefPubMed Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.CrossRefPubMed
19.
go back to reference Grignola JC. Is the time constant of the pulmonary circulation truly constant? Eur Respir J. 2014;43:1539–41.CrossRefPubMed Grignola JC. Is the time constant of the pulmonary circulation truly constant? Eur Respir J. 2014;43:1539–41.CrossRefPubMed
20.
go back to reference Rodes-Cabau J, Domingo E, Roman A, Majo J, Lara B, Padilla F, et al. Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart. 2003;89:311–5.CrossRefPubMedPubMedCentral Rodes-Cabau J, Domingo E, Roman A, Majo J, Lara B, Padilla F, et al. Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart. 2003;89:311–5.CrossRefPubMedPubMedCentral
21.
go back to reference Grignola JC, Domingo E, Aguilar R, Vazquez M, Lopez-Messeguer M, Bravo C, et al. Acute absolute vasodilatation is associated with a lower vascular wall stiffness in pulmonary arterial hypertension. Int J Cardiol. 2013;164:227–31.CrossRefPubMed Grignola JC, Domingo E, Aguilar R, Vazquez M, Lopez-Messeguer M, Bravo C, et al. Acute absolute vasodilatation is associated with a lower vascular wall stiffness in pulmonary arterial hypertension. Int J Cardiol. 2013;164:227–31.CrossRefPubMed
22.
go back to reference Santana DB, Barra JG, Grignola JC, Gines FF, Armentano RL. Pulmonary artery smooth muscle activation attenuates arterial dysfunction during acute pulmonary hypertension. J Appl Physiol (1985). 2005;98:605–13.CrossRef Santana DB, Barra JG, Grignola JC, Gines FF, Armentano RL. Pulmonary artery smooth muscle activation attenuates arterial dysfunction during acute pulmonary hypertension. J Appl Physiol (1985). 2005;98:605–13.CrossRef
23.
go back to reference Domingo E, Grignola JC, Aguilar R, Montero MA, Arredondo C, Vazquez M, et al. In vivo assessment of pulmonary arterial wall fibrosis by intravascular optical coherence tomography in pulmonary arterial hypertension: a new prognostic marker of adverse clinical follow-up. Open Respir Med J. 2013;7:26–32.CrossRefPubMedPubMedCentral Domingo E, Grignola JC, Aguilar R, Montero MA, Arredondo C, Vazquez M, et al. In vivo assessment of pulmonary arterial wall fibrosis by intravascular optical coherence tomography in pulmonary arterial hypertension: a new prognostic marker of adverse clinical follow-up. Open Respir Med J. 2013;7:26–32.CrossRefPubMedPubMedCentral
24.
go back to reference Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–e19.CrossRefPubMed Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–e19.CrossRefPubMed
25.
go back to reference Hilde JM, Skjorten I, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, et al. Haemodynamic responses to exercise in patients with COPD. Eur Respir J. 2013;41:1031–41.CrossRefPubMed Hilde JM, Skjorten I, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, et al. Haemodynamic responses to exercise in patients with COPD. Eur Respir J. 2013;41:1031–41.CrossRefPubMed
26.
go back to reference Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2:286–95.CrossRefPubMed Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2:286–95.CrossRefPubMed
27.
go back to reference Shen JY, Cai ZY, Sun LY, Yang CD, He B. The application of intravascular ultrasound to evaluate pulmonary vascular properties and mortality in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr. 2016;29:103–11.CrossRefPubMed Shen JY, Cai ZY, Sun LY, Yang CD, He B. The application of intravascular ultrasound to evaluate pulmonary vascular properties and mortality in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr. 2016;29:103–11.CrossRefPubMed
28.
go back to reference Lau EM, Manes A, Celermajer DS, Galie N. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J. 2011;32:2489–98.CrossRefPubMed Lau EM, Manes A, Celermajer DS, Galie N. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J. 2011;32:2489–98.CrossRefPubMed
29.
go back to reference Portillo K, Torralba Y, Blanco I, Burgos F, Rodriguez-Roisin R, Rios J, et al. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1313–20.CrossRefPubMedPubMedCentral Portillo K, Torralba Y, Blanco I, Burgos F, Rodriguez-Roisin R, Rios J, et al. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1313–20.CrossRefPubMedPubMedCentral
30.
go back to reference Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. Eur Respir J. 2015;46:1370–7.CrossRefPubMed Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. Eur Respir J. 2015;46:1370–7.CrossRefPubMed
32.
go back to reference Levarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J. 2014;44:425–34.CrossRefPubMedPubMedCentral Levarge BL, Pomerantsev E, Channick RN. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J. 2014;44:425–34.CrossRefPubMedPubMedCentral
33.
go back to reference Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012;163:589–94.CrossRefPubMed Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012;163:589–94.CrossRefPubMed
34.
go back to reference Hoffmann J, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Kovacs G, et al. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med. 2014;190:98–111.CrossRefPubMed Hoffmann J, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Kovacs G, et al. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med. 2014;190:98–111.CrossRefPubMed
35.
go back to reference Boerrigter BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, Systrom DM. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J. 2014;43:1316–25.CrossRefPubMed Boerrigter BG, Waxman AB, Westerhof N, Vonk-Noordegraaf A, Systrom DM. Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects. Eur Respir J. 2014;43:1316–25.CrossRefPubMed
36.
go back to reference Hostler J, Brown AW, Sherner J, King CS, Nathan SD. Pulmonary hypertension in COPD. Eur Respir Monogr. 2013;59:189–205. Hostler J, Brown AW, Sherner J, King CS, Nathan SD. Pulmonary hypertension in COPD. Eur Respir Monogr. 2013;59:189–205.
37.
go back to reference Kubo K, Ge RL, Koizumi T, Fujimoto K, Yamanda T, Haniuda M, et al. Pulmonary artery remodeling modifies pulmonary hypertension during exercise in severe emphysema. Respir Physiol. 2000;120:71–9.CrossRefPubMed Kubo K, Ge RL, Koizumi T, Fujimoto K, Yamanda T, Haniuda M, et al. Pulmonary artery remodeling modifies pulmonary hypertension during exercise in severe emphysema. Respir Physiol. 2000;120:71–9.CrossRefPubMed
38.
go back to reference Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31:373–80.CrossRefPubMed Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31:373–80.CrossRefPubMed
39.
go back to reference Nathan SD, Cottin V. Pulmonary hypertension in patients with idiopatic pulmonary fibrosis. Eur Respir Monogr. 2012;57:148–60. Nathan SD, Cottin V. Pulmonary hypertension in patients with idiopatic pulmonary fibrosis. Eur Respir Monogr. 2012;57:148–60.
40.
go back to reference Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol. 2011;45:1–15.CrossRefPubMed Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol. 2011;45:1–15.CrossRefPubMed
41.
go back to reference Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015;24:642–52.CrossRefPubMed Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015;24:642–52.CrossRefPubMed
42.
go back to reference Boerrigter B, Trip P, Bogaard HJ, Groepenhoff H, Oosterveer F, Westerhof N, et al. Right atrial pressure affects the interaction between lung mechanics and right ventricular function in spontaneously breathing COPD patients. Plos One. 2012;7:e30208.CrossRefPubMedPubMedCentral Boerrigter B, Trip P, Bogaard HJ, Groepenhoff H, Oosterveer F, Westerhof N, et al. Right atrial pressure affects the interaction between lung mechanics and right ventricular function in spontaneously breathing COPD patients. Plos One. 2012;7:e30208.CrossRefPubMedPubMedCentral
43.
go back to reference Oliveira RK, Agarwal M, Tracy JA, Karin AL, Opotowsky AR, Waxman AB, et al. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics. Eur Respir J. 2016;47:1179–88.CrossRefPubMed Oliveira RK, Agarwal M, Tracy JA, Karin AL, Opotowsky AR, Waxman AB, et al. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics. Eur Respir J. 2016;47:1179–88.CrossRefPubMed
Metadata
Title
Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation
Authors
Enric Domingo
Juan C. Grignola
Rio Aguilar
Manuel López Messeguer
Antonio Roman
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2017
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-017-0568-z

Other articles of this Issue 1/2017

Respiratory Research 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.